HARBINGER HEALTH
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97164498
- Registration number
- 7589143
- Mark type
- Stylized text
- Filed
- 09 Dec 2021
- Published for opposition
- 02 May 2023
- Registered
- 03 Dec 2024
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and pharmaceutical preparations comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for the treatment and diagnosis of cancer
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Diagnostic services for use in the treatment and diagnosis of cancer
Owner
- Harbinger Health, Inc., Cambridge, MA, US
- Harbinger Health, Inc., Cambridge, MA, US
- Harbinger Oncology, Inc., CAMBRIDGE, MA, US
- Harbinger Oncology, Inc., Cambridge, MA, US
Prosecution history
- 05 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2024 — USE AMENDMENT FILED
- 13 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2024 — SOU EXTENSION 2 GRANTED
- 24 Jun 2024 — SOU EXTENSION 2 FILED
- 24 Jun 2024 — SOU TEAS EXTENSION RECEIVED